AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA, Inc., 583 F.3d 766, CPLRG 0005 (Fed. Cir. 2009) astrazenecateva09252009
MAJOR ISSUES: inequitable conduct, no intent to deceive, disclosure of comparative data as requested by examiner to overcome obviousness rejection, failure to disclose internal data on other related compounds, failure to synthesize compounds for comparative testing
Twelfth Annual Federal Circuit Judicial Conference, United States Court of Appeals for the Federal Circuit, Washington D.C., June 16, 1994. 159 F.R.D. 59,
The Ninth Annual Judicial Conference of the United States Court of Appeals for the Federal Circuit, Washington, D.C., May 9, 1991, published at 140 F.R.D. 57.
The Seventh Annual Judicial Conference of the United States Court of Appeals for the Federal Circuit, Washington, D.C., May 24, 1989, published at 128 F.R.D. 409.
The Fifth Annual Judicial Conference of the United States Court of Appeals for the Federal Circuit, Washington, D.C., May 8, 1987, published at 119 F.R.D. 45.
